← Back to case list

Good Doctor Pharmaceutical · Big health industry group
Good Doctor Pharmaceutical | Compliant archiving of fully digitalized e-invoices, Phase I implemented in 2-3 months
37 companiesWholly owned subsidiary
2-3 monthsPhase I implementation cycle
Enterprise overview
After more than 30 years of development, Good Doctor Pharmaceutical Group Co., Ltd. has become a "big health" industry group integrating science, industry, and trade with biopharmaceuticals at its core. Its business covers seven major segments: pharmaceutical industry, commerce, R&D, healthcare, cultivation and breeding of Chinese medicinal materials, agricultural product processing, and big health. It has 37 wholly owned subsidiaries, 1 internet healthcare platform company, and 3 pharmaceutical trading companies. Its current informatization includes Weaver OA, Yonyou NC, and Kingdee output invoicing.
Business pain points
- Under China Golden Tax Phase IV, with the spread of fully digitalized e-invoices and changes in invoice forms and policies, enterprises still manage fully digitalized e-invoices the way they managed paper invoices under China Golden Tax Phase III, resulting in low management efficiency, high costs, and non-compliance (for example, tax authorities require that fully digitalized e-invoices must retain original files, and archiving must retain both the original file and the XML electronic file)
Solutions
- Phase I: The input VAT invoice management system is integrated with Weaver OA, and the electronic imaging and electronic accounting archives management system is deployed
- Phase II: Replace Kingdee Invoice Cloud products to enable unified construction and management of tax informatization
Results achieved
- Reduce costs and increase efficiency, cut redundant management processes and shorten processing cycles
- Ensure business-finance-tax compliance under China Golden Tax Phase IV and the latest paperless policies of the Archives Bureau
